Bacterial resistance and new treatment strategies - Staphylococcal infections

Citation
E. Bergogne-berezin, Bacterial resistance and new treatment strategies - Staphylococcal infections, PRESSE MED, 29(37), 2000, pp. 2018-2021
Citations number
1
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
PRESSE MEDICALE
ISSN journal
07554982 → ACNP
Volume
29
Issue
37
Year of publication
2000
Pages
2018 - 2021
Database
ISI
SICI code
0755-4982(200012)29:37<2018:BRANTS>2.0.ZU;2-X
Abstract
MRSA outside the hospital: From a major problem almost exclusively encounte red in hospitalized patients, meticillin-resistant Staphylococcus aureus (M RSA) infection has become a cause of skin, soft tissue, and even systemic i nfections outside the hospital. In order to prevent further spread, patient s carrying MRSA (recently hospitalized patients, drug abusers, debilitated subjects, etc) must be identified and the mode of acquisition of MRSA infec tion (cross transmission between community and non-hospital care centers) m ust be recognized. Small colony variants: SCV produce non-pigmented colonies that ale 10 times smaller than the usual S. aureus colonies and have particular metabolic an d genetic properties. They can cause persistent, recurrent and drug-resista nt infections. MRSA in France: Data obtained in a case-control study confirms the selectio n pressure as well as the important colonization pressure exerted by antibi otics on gentamicin-sensitive strains. (C) 2000, Masson, Paris.